JAC Advance Access published online on August 10, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl326
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratoire d'études de génétique bactérienne dans les infections de l'enfant (EA3105), Université Denis Diderot-Paris 7, AP-HP, Hôpital Robert Debré, Service de Microbiologie, 75019 Paris, France
* To whom correspondence should be addressed. We studied 100 well-characterized E. coli blood isolates from patients with urosepsis for their susceptibility to nalidixic acid, ampicillin and trimethoprim-sulfamethoxazole, according to prevalence of virulence factors, phylogenetic groups and subgroups, PAI IIJ96-like domains (determined by physical linkage of cnf1, hly and hra) and PAI ICFT073-like domains (determined by physical linkage of papGII to the hly locus). Nalidixic acid resistance was associated with a lower prevalence of sfa/foc, K1 antigen, pathogenicity island IIJ96-like domains, subgroup B2/I and a shift towards group A.
Received March 22, 2006
Revised July 6, 2006
Accepted July 14, 2006
Original article
Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates
Véronique Houdouin 1, Stéphane Bonacorsi 1, Philippe Bidet 1, Martine Bingen-Bidois 2, Dominique Barraud 2, and Edouard Bingen 1 *
2 Laboratoire de Bactériologie, Centre Hospitalier de Gonesse, Gonesse, France
Edouard Bingen, E-mail: edouard.bingen{at}rdb.ap-hop-paris.fr
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Z. Petkovsek, K. Elersic, M. Gubina, D. Zgur-Bertok, and M. Starcic Erjavec Virulence Potential of Escherichia coli Isolates from Skin and Soft Tissue Infections J. Clin. Microbiol., June 1, 2009; 47(6): 1811 - 1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Lloyd, T. A. Henderson, P. D. Vigil, and H. L. T. Mobley Genomic Islands of Uropathogenic Escherichia coli Contribute to Virulence J. Bacteriol., June 1, 2009; 191(11): 3469 - 3481. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takahashi, T. Muratani, M. Yasuda, S. Takahashi, K. Monden, K. Ishikawa, H. Kiyota, S. Arakawa, T. Matsumoto, H. Shima, et al. Genetic Profiles of Fluoroquinolone-Resistant Escherichia coli Isolates Obtained from Patients with Cystitis: Phylogeny, Virulence Factors, PAIusp Subtypes, and Mutation Patterns J. Clin. Microbiol., March 1, 2009; 47(3): 791 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rijavec, M. Muller-Premru, B. Zakotnik, and D. Zgur-Bertok Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin J. Med. Microbiol., November 1, 2008; 57(11): 1329 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bronowski, S. L. Smith, K. Yokota, J. E. Corkill, H. M. Martin, B. J. Campbell, J. M. Rhodes, C. A. Hart, and C. Winstanley A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli Microbiology, February 1, 2008; 154(2): 571 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Piatti, A. Mannini, M. Balistreri, and A. M. Schito Virulence Factors in Urinary Escherichia coli Strains: Phylogenetic Background and Quinolone and Fluoroquinolone Resistance J. Clin. Microbiol., February 1, 2008; 46(2): 480 - 487. [Abstract] [Full Text] [PDF] |
||||



